Durvalumab is used to treat non-small cell lung cancer (NSCLC), biliary tract cancer, liver cancer, and endometrial cancer. It's often prescribed when these cancers are advanced or unresectable.

Q. How is Durvalumab administered?

Durvalumab is given as an intravenous (IV) infusion, typically in a hospital or clinic setting, under the supervision of a healthcare provider.

Q. What should I expect during treatment with Durvalumab?

You may experience side effects like fatigue, cough, or appetite loss. It's important to report any severe symptoms to your doctor right away.

Q. Can I take Durvalumab with other medications?

You should inform your doctor of all medications and supplements you are taking, as Durvalumab can interact with other drugs.

Q. What precautions should I take while on treatment with Durvalumab?

Avoid exposure to infections, report any unusual symptoms, and discuss your medical history with your doctor, especially if you have autoimmune conditions, are pregnant, or breastfeeding.

Q. How long will I need to be on Durvalumab?

The duration of treatment with Durvalumab depends on your specific cancer type, response to the treatment, and overall health. Your doctor will determine the best treatment plan for you.